Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Catalent Inc (CTLT)

Catalent Inc (CTLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.

NVO : 140.80 (+0.31%)
BMO : 84.16 (+0.44%)
CTLT : 55.07 (-0.25%)
HIMS : 24.79 (+2.65%)
LLY : 891.46 (+0.73%)
Catalent: Fiscal Q3 Earnings Snapshot

Catalent: Fiscal Q3 Earnings Snapshot

CTLT : 55.07 (-0.25%)
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?

All three of these high-flying stocks could have more room to run.

CTLT : 55.07 (-0.25%)
NVO : 140.80 (+0.31%)
LLY : 891.46 (+0.73%)
VKTX : 50.64 (-2.65%)
Did Novo Nordisk Just Get a Jump on Eli Lilly?

A recent FDA announcement may have just put one company in the lead.

LLY : 891.46 (+0.73%)
CTLT : 55.07 (-0.25%)
NVO : 140.80 (+0.31%)
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why

Eli Lilly and Novo Nordisk dominate the diabetes market thanks to blockbuster medications Mounjaro, Ozempic, and Rybelsus.

CTLT : 55.07 (-0.25%)
LLY : 891.46 (+0.73%)
NVO : 140.80 (+0.31%)
Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's...

CTLT : 55.07 (-0.25%)
LVMUY : 152.4600 (-1.70%)
Novo Nordisk Is Scaling a Barrier to Growth. Should You Buy Its Stock Now?

Even more revenue is on the way from additional sales of Wegovy.

LLY : 891.46 (+0.73%)
CTLT : 55.07 (-0.25%)
NVO : 140.80 (+0.31%)
Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited

Novo Nordisk just made a unique acquisition to help bolster the supply of Wegovy and Ozempic.

CTLT : 55.07 (-0.25%)
NVO : 140.80 (+0.31%)
Catalent: Fiscal Q2 Earnings Snapshot

Catalent: Fiscal Q2 Earnings Snapshot

CTLT : 55.07 (-0.25%)
Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?

Healthcare stocks LLY and NVO have crushed broader market returns in the past two decades. But with competition heating up over obesity drugs, which mega-cap stock is a better buy today?

NVO : 140.80 (+0.31%)
LLY : 891.46 (+0.73%)
CTLT : 55.07 (-0.25%)

Barchart Exclusives

Is This Industrial Stock a Buy After Its Latest Dividend Hike?
As this heavy machinery giant raises its quarterly payouts, should investors consider the industrial stock? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar